The prevalence of hyperprolactinemia in patients with primary Sjogren's syndrome

Journal of Rheumatology

Volumn 26, Issue 6, 1999, Pages 1291-1295

  Haga, Hans Jacob ^a   Rygh, Tore ^b  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b NONE

Author keywords

Primary Sjogren's syndrome; Prolactin

Indexed keywords

AUTOANTIBODY; IMMUNOGLOBULIN; PROLACTIN;

ADULT; AGE DISTRIBUTION; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; BIOPSY; CONTROLLED STUDY; DISEASE DURATION; FEMALE; HUMAN; HYPERPROLACTINEMIA; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MINOR SALIVA GLAND; PREVALENCE; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; SJOEGREN SYNDROME;

ADULT; AGE FACTORS; AGE OF ONSET; AGED; ANTIBODIES, ANTINUCLEAR; FEMALE; HUMANS; HYPERPROLACTINEMIA; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; PROLACTIN; RHEUMATOID FACTOR; SJOGREN'S SYNDROME;

EID: 0033063210     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Chikanza IC, Panayi GS. Hypothalamic-pituitary mediated modulation of immune function: prolactin as a neuroimmune peptide. Br J Rheumatol 1991;30:203-7.
2. Matera L, Bellone G, Cesano A. Prolactin and the immune network. Adv Neuroimmunol 1991;1:158-72.
3. Berczi I. The immunology of prolactin. Semin Reprod Endocrinol 1992;10:196-219.
4. Neidhart M. Prolactin in autoimmune diseases. Proc Soc Exp Med 1998;217:408-17.
5. Russel DH, Matrisian L, Kibler R, Larson DF, Poulos B, Magun BE. Prolactin receptors on human lymphocytes and their modulation by cyclosporine. Biochem Biophys Res Commun 1984;121:899-906.
6. Russel DH, Kibler R, Matrisian L, Larson DG, Poulos B, Magun BE. Prolactin receptors on human T and B lymphocytes: antagonism of prolactin binding by cyclosporine. J Immunol 1985;134:3027-31.
7. Matera L, Muccioli G, Cesano A, Bellussi G, Genazzani E. Prolactin receptors on large granular lymphocytes: dual regulation by cyclosporin A. Brain Behav Immun 1988;2:1-10.
8. Ferrai C, Boghen M, Paracchi A. Thyroid autoimmunity in hyperprolactinemic disorders Acta Endocrinol 1983;104:35-41.
9. Lever EG, McKerron CG. Autoimmune Addison's disease associated with hyperprolactinemia. Clin Endocrinol 1984; 21:451-7.
10. Jara LJ, Gomez-Sanchez C, Silveria LH, Martinez-Osuna P, Vasey FB, Espinoza LR. Hyperprolactinemia in systemic lupus erythematosus: association with disease. Am J Med Sci 1992;303:222-6.
11. Neidhart M. Elevated serum prolactin or elevated prolactin/ cortiosol ratio are associated with autoimmune processes in systemic lupus erythematosus and other connective tissue diseases. J Rheumatol 1996;23:476-81.
12. Allen SH, Sharp GC, Wang G, et al. Prolactin levels and antinuclear antibody profiles in women tested for connective tissue disease. Lupus 1996;5:30-7.
13. Walker SE, Allen SH, Hoffman RW, McMurray RW. Prolactin: a stimulator of disease activity in systemic lupus erythematosus. Lupus 1995;4:3-9.
14. Buskila D, Sukenik S, Holcberg G, Horowitz J. Improvement of psoriatic arthritis in a patient treated with bromocriptine for hyperprolactinemia. J Rheumatol 1991;18:611-2.
15. Hedner LP, Bynke G. Endogenous iridocyclitis relieved during treatment with bromocriptine. Am J Ophthalmol 1985;100:618-9.
16. Bravo G, Zazueta B, Lavalle C. An acute remission of Reiter's syndrome in male patients treated with bromocriptine. J Rheumatol 1992;19:747-50.
17. McMurray RW, Allen SH, Braun AL, Rodriguez F, Walker SE. Longstanding hyperprolactinemia associated with systemic lupus erythematosus: possible hormonal stimulation of an autoimmune disease. J Rheumatol 1994;21:843-50.
18. Buskila D, Lorber M, Neumann L, Flusser D, Shoenfeld Y. No correlation between prolactin levels and clinical activity in patients with systemic lupus erythematosus. J Rheumatol 1996;23:629-32.
19. Ostendorf B, Fischer R, Santen R, Scmitz-Linneweber B, Specker C, Schneider M. Hyperprolactinemia in systemic lupus erythematosus? Scand J Rheumatol 1996;25:97-102.
20. Gutierrez MA, Anaya JM, Scopelitis E, Citera G, Solveira LH, Espinoza LR. Hyperprolactinemia in primary Sjögren's syndrome? Ann Rheum Dis 1994;53:425-8.
21. Braesch-Andersen S, Paulie S, Stamenkovic I. Dopamine induced lymphoma cell death by inhibition of hormone release. Scand J Immunol 1992;36:547-53.
22. Walker SE, McMurray RW, Besch-Williford CL, Keisler DH. Premature death with bladder outlet obstruction and hyperprolactinemia in New Zealand Black × New Zealand White mice treated with ethinyl estradiol and 17 beta-estradiol. Arthritis Rheum 1992;35:1387-92.
23. Kassan SS, Thomas TL, Moutsopoulos HM, et al. Increased risk of lymphoma in sicca syndrome. Ann Intern Med 1978;89:888-92.
24. Vitali C, Bombardieri S, Moutsopoulos HM, et al. Preliminary criteria for the classification of Sjögren's syndrome. Results of an EEC prospective concerted action. Arthritis Rheum 1993;36:340-7.
25. Greenspan JS, Daniels TE, Talal N, Sylvester RA. The histopathology of Sjögren's syndrome in labial salivary gland biopsies. Oral Surg 1974;37:217-29.
26. Asmussen K, Andersen V, Bendixen G, et al. Quantitative assessment of clinical disease status in primary Sjögren's syndrome. Scand J Rheumatol 1997;26:197-205.
27. Kriegbaum NJ, von Linstow M, Oxholm P, Prause JU. Keratoconjunctivitis sicca in primary Sjögren's syndrome. A longitudinal study of ocular parameters. Acta Ophthalmol 1988;66:481-4.
28. Johnson EO, Vlachoyiannopoulos PG, Skopouli FN, Tzioufas AG, Moutsopoulos HM. Hypofunction of the stress axis in Sjögren's syndrome. J Rheumatol 1998;25:1508-14.
29. Batrinos ML, Panitsa-Faflia C, Tsiganou E, Liapi C. Incidence and characteristics of microprolactinomas (3-5 mm) in 4199 women assayed for prolactin. Horm Metab Res 1992;24:384-91.
30. Garcia-Carrasco M, Font J, Gaya J, et al. Prolactin levels in patients with primary Sjögren's syndrome. Br J Rheumatol 1997;36 Suppl:25.
31. Haga H-J, Jonsson R. The influence of age on clinical features and laboratory findings in primary Sjögren's syndrome [abstract]. Clin Exp Rheumatol 1998;16:235.
32. Hou SH, Grossman S, Molitch ME. Hyperprolactinemia in patients with renal insufficiency and chronic renal failure requiring hemodialysis or chronic ambulatory peritoneal dialysis. Am J Kidney Dis 1985;6:245-9.
33. Morgan MY, Jakobovits AW, Gore MB, Wills MR, Sherlock S. Serum prolactin in liver disease and its relationship to gynecomastia. Gut 1978;19:170-4.
34. Kawai T, Katoh K, Tani K. Hyperprolactinemia preceding development of autoimmune diseases. J Rheumatol 1996; 23:1483-4.
35. Jara-Quezada LJ, Lavalle C, Espinoza LR. Does prolactin have a role in the pathogenesis of systemic lupus erythematosus? J Rheumatol 1992;19:1333-6.